{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T13:24:13Z","timestamp":1765545853194},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,11,21]],"date-time":"2013-11-21T00:00:00Z","timestamp":1384992000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cardiovasc Drugs Ther"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1007\/s10557-013-6503-8","type":"journal-article","created":{"date-parts":[[2013,11,20]],"date-time":"2013-11-20T06:18:35Z","timestamp":1384928315000},"page":"125-135","source":"Crossref","is-referenced-by-count":28,"title":["AT1 and Aldosterone Receptors Blockade Prevents the Chronic Effect of Nandrolone on the Exercise-Induced Cardioprotection in Perfused rat Heart Subjected to Ischemia and Reperfusion"],"prefix":"10.1007","volume":"28","author":[{"given":"Silvio Rodrigues","family":"Marques-Neto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emanuelle Baptista","family":"Ferraz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deivid Carvalho","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Njaine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edson","family":"Rondinelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ant\u00f4nio Carlos","family":"Campos de Carvalho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose Hamilton Matheus","family":"Nascimento","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,11,21]]},"reference":[{"key":"6503_CR1","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1161\/CIRCULATIONAHA.107.187998","volume":"117","author":"W Rosamond","year":"2008","unstructured":"Rosamond W, Flegal K, Furie K, Go A, Greenlund K, Haase N, et al. Heart Disease and Stroke Statistics\u20132008 Update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2008;117:e25\u2013e146.","journal-title":"Circulation"},{"key":"6503_CR2","unstructured":"World Health Organization. Cardiovascular diseases (CVDs). Fact sheet No. 317, 2011."},{"key":"6503_CR3","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1161\/01.CIR.99.7.963","volume":"99","author":"RJ Shephard","year":"1999","unstructured":"Shephard RJ, Balady GJ. Exercise as cardiovascular therapy. Circulation. 1999;99:963\u201372.","journal-title":"Circulation"},{"key":"6503_CR4","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1161\/01.CIR.0000048890.59383.8D","volume":"107","author":"J Myers","year":"2003","unstructured":"Myers J. Cardiology patient pages. Exercise and cardiovascular health. Circulation. 2003;107:e2\u20135.","journal-title":"Circulation"},{"key":"6503_CR5","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1249\/mss.0b013e3180616b27","volume":"39","author":"WL Haskell","year":"2007","unstructured":"Haskell WL, Lee IM, Pate RR, Powell KE, Blair SN, Franklin BA, et al. Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association. Med Sci Sports Exerc. 2007;39:1423\u201334.","journal-title":"Med Sci Sports Exerc"},{"key":"6503_CR6","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1161\/CIRCULATIONAHA.107.185650","volume":"116","author":"ME Nelson","year":"2007","unstructured":"Nelson ME, Rejeski WJ, Blair SN, Duncan PW, Judge JO, King AC, et al. Physical activity and public health in older adults: recommendation from the American College of Sports Medicine and the American Heart Association. Circulation. 2007;116:1094\u2013105.","journal-title":"Circulation"},{"key":"6503_CR7","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.2165\/00007256-200838120-00005","volume":"38","author":"FP Leung","year":"2008","unstructured":"Leung FP, Yung LM, Laher I, Yao X, Chen ZY, Huang Y. Exercise, vascular wall and cardiovascular diseases: an update (part 1). Sports Med. 2008;38:1009\u201324.","journal-title":"Sports Med"},{"key":"6503_CR8","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1161\/01.CIR.57.5.958","volume":"57","author":"CL McElroy","year":"1978","unstructured":"McElroy CL, Gissen SA, Fishbein MC. Exercise-induced reduction in myocardial infarct size after coronary artery occlusion in the rat. Circulation. 1978;57:958\u201362.","journal-title":"Circulation"},{"key":"6503_CR9","doi-asserted-by":"crossref","first-page":"H804","DOI":"10.1152\/ajpheart.1992.263.3.H804","volume":"263","author":"DK Bowles","year":"1992","unstructured":"Bowles DK, Farrar RP, Starnes JW. Exercise training improves cardiac function after ischemia in the isolated, working rat heart. Am J Physiol Heart Circ Physiol. 1992;263:H804\u20139.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"6503_CR10","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1136\/heart.85.3.331","volume":"85","author":"N Yamashita","year":"2001","unstructured":"Yamashita N, Baxter GF, Yellon DM. Exercise directly enhances myocardial tolerance to ischemia-reperfusion injury in the rat through a protein kinase C mediated mechanism. Heart. 2001;85:331\u20136.","journal-title":"Heart"},{"key":"6503_CR11","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1161\/CIRCULATIONAHA.110.939959","volume":"122","author":"S Gielen","year":"2010","unstructured":"Gielen S, Schuler G, Adams V. Cardiovascular effects of exercise training\u2013molecular mechanisms. Circulation. 2010;122:1221\u201338.","journal-title":"Circulation"},{"key":"6503_CR12","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1152\/japplphysiol.00004.2011","volume":"111","author":"CR Frasier","year":"2011","unstructured":"Frasier CR, Moore RL, Brown DA. Exercise-induced cardiac preconditioning: how exercise protects your achy-breaky heart. J Appl Physiol. 2011;111:905\u201315.","journal-title":"J Appl Physiol"},{"key":"6503_CR13","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1113\/jphysiol.2005.095729","volume":"569","author":"DA Brown","year":"2005","unstructured":"Brown DA, Chicco AJ, Jew KN, Johnson MS, Lynch JM, Watson PA, et al. Cardioprotection afforded by chronic exercise is mediated by sarcolemmal, and not the mitochondrial, isoform of the KATP channel in the rat. J Physiol. 2005;569:913\u201324.","journal-title":"J Physiol"},{"key":"6503_CR14","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1113\/jphysiol.2004.081323","volume":"564","author":"DA Brown","year":"2005","unstructured":"Brown DA, Lynch JM, Armstrong CJ, Caruso NM, Ehlers LB, Johnson MS, et al. Susceptibility of the heart to ischaemia-reperfusion injury and exercise-induced cardioprotection are sex-dependent in the rat. J Physiol. 2005;564:619\u201330.","journal-title":"J Physiol"},{"key":"6503_CR15","doi-asserted-by":"crossref","first-page":"H2432","DOI":"10.1152\/ajpheart.01301.2006","volume":"292","author":"AJ Chicco","year":"2007","unstructured":"Chicco AJ, Johnson MS, Armstrong CJ, Lynch JM, Gardner RT, Fasen GS, et al. Sex-specific and exercise-acquired cardioprotection is abolished by sarcolemmal KATP channel blockade in the rat heart. Am J Physiol Heart Circ Physiol. 2007;292:H2432\u20137.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"6503_CR16","doi-asserted-by":"crossref","first-page":"H175","DOI":"10.1152\/ajpheart.01211.2009","volume":"299","author":"JC Quindry","year":"2010","unstructured":"Quindry JC, Schreiber L, Hosick P, Wrieden J, Irwin JM, Hoyt E. Mitochondrial KATP channel inhibition blunts arrhythmia protection in ischemic exercised hearts. Am J Physiol Heart Circ Physiol. 2010;299:H175\u201383.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"6503_CR17","doi-asserted-by":"crossref","first-page":"513","DOI":"10.2165\/00007256-200434080-00003","volume":"34","author":"F Hartgens","year":"2004","unstructured":"Hartgens F, Kuipers H. Effects of androgenic-anabolic steroids in athletes. Sports Med. 2004;34:513\u201354.","journal-title":"Sports Med"},{"key":"6503_CR18","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1016\/S0140-6736(08)60801-6","volume":"371","author":"F Sj\u04e7qvist","year":"2008","unstructured":"Sj\u04e7qvist F, Garle M, Rane A. Use of doping agents, particularly anabolic steroids, in sports and society. Lancet. 2008;371:1872\u201382.","journal-title":"Lancet"},{"key":"6503_CR19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0033-0620(98)80019-4","volume":"41","author":"ML Sullivan","year":"1998","unstructured":"Sullivan ML, Martinez CM, Gennis P, Gallagher EJ. The cardiac toxicity of anabolic steroids. Prog Cardiovasc Dis. 1998;41:1\u201315.","journal-title":"Prog Cardiovasc Dis"},{"key":"6503_CR20","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ijcard.2005.11.033","volume":"114","author":"M Paolo Di","year":"2007","unstructured":"Di Paolo M, Agozzino M, Toni C, Luciani AB, Molendini L, Scaglione M, et al. Sudden anabolic steroid abuse-related death in athletes. Int J Cardiol. 2007;114:114\u20137.","journal-title":"Int J Cardiol"},{"key":"6503_CR21","doi-asserted-by":"crossref","first-page":"253","DOI":"10.5858\/2001-125-0253-ASAACS","volume":"125","author":"V Fineschi","year":"2001","unstructured":"Fineschi V, Baroldi G, Monciotti F, Reattelli LP, Turillazzi E. Anabolic steroid abuse and cardiac sudden death: a pathologic study. Arch Pathol Lab Med. 2001;125:253\u20135.","journal-title":"Arch Pathol Lab Med"},{"key":"6503_CR22","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1136\/hrt.2003.015719","volume":"90","author":"A Urhausen","year":"2004","unstructured":"Urhausen A, Albers T, Kindermann W. Are the cardiac effects of anabolic steroid abuse in strength athletes reversible? Heart. 2004;90:496\u2013501.","journal-title":"Heart"},{"key":"6503_CR23","first-page":"21","volume":"16","author":"EF Toit Du","year":"2005","unstructured":"Du Toit EF, Rossouw E, Van Rooyen J, Lochner A. Proposed mechanisms for the anabolic steroid-induced increase in myocardial susceptibility to ischemia\/reperfusion injury. Cardiovasc J South Afr. 2005;16:21\u20138.","journal-title":"Cardiovasc J South Afr"},{"key":"6503_CR24","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jsbmb.2006.01.004","volume":"99","author":"EA Chaves","year":"2006","unstructured":"Chaves EA, Pereira-Junior PP, Fortunato RS, Masuda MO, Carvalho ACC, Carvalho DP, et al. Nandrolone decanoate impairs exercise-induced cardioprotection: role of antioxidant enzymes. J Steroid Biochem Mol Biol. 2006;99:223\u201330.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"6503_CR25","doi-asserted-by":"crossref","first-page":"H3575","DOI":"10.1152\/ajpheart.01251.2006","volume":"293","author":"FL Rocha","year":"2007","unstructured":"Rocha FL, Carmo EC, Roque FR, Hashimoto NY, Rossoni LV, Frimm C, et al. Anabolic steroids induce cardiac renin-angiotensin system and impair the beneficial effects of aerobic training in rats. Am J Physiol Heart Circ Physiol. 2007;293:H3575\u201383.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"6503_CR26","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1249\/MSS.0b013e318217e8b6","volume":"43","author":"EC Do Carmo","year":"2011","unstructured":"Do Carmo EC, Fernandes T, Koike D, Da Silva Jr ND, Mattos KC, Rosa KT, et al. Anabolic steroid associated to physical training induces deleterious cardiac effects. Med Sci Sports Exerc. 2011;43:1836\u201348.","journal-title":"Med Sci Sports Exerc"},{"key":"6503_CR27","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1161\/01.CIR.98.3.256","volume":"98","author":"JD Marsh","year":"1998","unstructured":"Marsh JD, Lehmann MH, Ritchie RH, Gwathmey JK, Green GE, Schiebinger RJ. Androgen receptors mediate hypertrophy in cardiac myocytes. Circulation. 1998;98:256\u201361.","journal-title":"Circulation"},{"key":"6503_CR28","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1161\/01.CIR.92.9.2690","volume":"92","author":"N Iwai","year":"1995","unstructured":"Iwai N, Shimoike H, Kinoshita M. Cardiac rennin-angiotensin system in the hypertrophied heart. Circulation. 1995;92:2690\u20136.","journal-title":"Circulation"},{"key":"6503_CR29","doi-asserted-by":"crossref","first-page":"R381","DOI":"10.1152\/ajpregu.00933.2007","volume":"295","author":"VG Barauna","year":"2008","unstructured":"Barauna VG, Magalhaes FC, Krieger JE, Oliveira EM. AT1 receptor participates in the cardiac hypertrophy induced by resistance training in rats. Am J Physiol Regul Integr Comp Physiol. 2008;295:R381\u20137.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"6503_CR30","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1161\/HYPERTENSIONAHA.108.117531","volume":"52","author":"AD Zhang","year":"2008","unstructured":"Zhang AD, Cat AND, Soukaseum C, Escoubet B, Cherfa A, Messaoudi S, et al. Cross-talk between mineralocorticoid and angiotensin II signaling for cardiac remodeling. Hypertension. 2008;52:1060\u20137.","journal-title":"Hypertension"},{"key":"6503_CR31","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1161\/01.CIR.0000015603.84788.47","volume":"105","author":"D Kalra","year":"2002","unstructured":"Kalra D, Sivasubramanian N, Mann DL. Angiotensin II induces tumor necrosis factor biosynthesis in the adult mammalian heart through a protein kinase C\u2013dependent pathway. Circulation. 2002;105:2198\u2013205.","journal-title":"Circulation"},{"key":"6503_CR32","doi-asserted-by":"crossref","unstructured":"Nakamura K, Fushimi K, Kouchi H, Mihara K, Miyazaki M, Ohe T, et al. Inhibitory effects of antioxidants on neonatal rat cardiac myocyte hypertrophy induced by tumor necrosis factor-\u03b1 and angiotensin II. 1998;98:794\u20139.","DOI":"10.1161\/01.CIR.98.8.794"},{"key":"6503_CR33","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1093\/cvr\/cvp162","volume":"83","author":"NI Tavares","year":"2009","unstructured":"Tavares NI, Philip-Couderc P, Baertschi AJ, Lerch R, Montessuit C. Angiotensin II and tumour necrosis factor \u03b1 as mediators of ATP-dependent potassium channel remodeling in post-infarction heart failure. Cardiovasc Res. 2009;83:726\u201336.","journal-title":"Cardiovasc Res"},{"key":"6503_CR34","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1097\/FJC.0b013e3180325ad9","volume":"49","author":"FC Serejo","year":"2007","unstructured":"Serejo FC, Rodrigues-Junior LF, Tavares KCS, Campos de Carvalho AC, Nascimento JHM. Cardioprotective properties of humoral factors released from rat hearts subject to ischemic preconditioning. J Cardiovasc Pharmacol. 2007;49:214\u201320.","journal-title":"J Cardiovasc Pharmacol"},{"key":"6503_CR35","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nprot.2008.73","volume":"3","author":"TD Schmittgen","year":"2008","unstructured":"Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative CT method. Nat Protoc. 2008;3:1101\u20138.","journal-title":"Nat Protoc"},{"key":"6503_CR36","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1161\/01.HYP.33.4.981","volume":"33","author":"V Robert","year":"1999","unstructured":"Robert V, Heymes C, Silvestre JS, Sabri A, Swynghedauw B, Delcayre C. Angiotensin AT1 receptor subtype as a cardiac target of aldosterone: role in aldosterone-salt-induced fibrosis. Hypertension. 1999;33:981\u20136.","journal-title":"Hypertension"},{"key":"6503_CR37","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1161\/hc0602.104675","volume":"105","author":"Y Takeda","year":"2002","unstructured":"Takeda Y, Yoneda T, Demura M, Usukura M, Mabuchi H. Calcineurin inhibition attenuates mineralocorticoid-induced cardiac hypertrophy. Circulation. 2002;105:677\u20139.","journal-title":"Circulation"},{"key":"6503_CR38","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1161\/01.CIR.99.20.2694","volume":"99","author":"JS Silvestre","year":"1999","unstructured":"Silvestre JS, Heymes C, Oub\u00e9na\u00efssa A, Robert V, Aupetit-Faisant B, Carayon A, et al. Activation of cardiac aldosterone production in rat myocardial infarction. Circulation. 1999;99:2694\u2013701.","journal-title":"Circulation"},{"key":"6503_CR39","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1161\/01.HYP.20.1.67","volume":"20","author":"ME Ullian","year":"1992","unstructured":"Ullian ME, Schelling JR, Linas SL. Aldosterone enhances angiotensin II receptor binding and inositol phosphate responses. Hypertension. 1992;20:67\u201373.","journal-title":"Hypertension"},{"key":"6503_CR40","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1046\/j.1440-1681.2003.03906.x","volume":"30","author":"JG Mill","year":"2003","unstructured":"Mill JG, Milanez MC, Rezende MM, Gomes MGS, Leite CM. Spironolactone prevents cardiac collagen proliferation after myocardial infarction in rats. Clin Exp Pharmacol Physiol. 2003;30:739\u201344.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"6503_CR41","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/sj.bjp.0706220","volume":"145","author":"W Chai","year":"2005","unstructured":"Chai W, Garrelds IM, Arulmani U, Schoemaker RG, Lamers JMJ, Danser AHJ. Genomic and nongenomic effects of aldosterone in the rat: why is spironolactone cardioprotective. Br J Pharmacol. 2005;145:664\u201371.","journal-title":"Br J Pharmacol"},{"issue":"Supl 3","key":"6503_CR42","first-page":"346","volume":"102","author":"M Sato","year":"2000","unstructured":"Sato M, Engelman RM, Otani H, Maulik N, Rousou JA, Flack III JE, et al. Myocardial protection by preconditioning of heart with losartan, na angiotensin II type 1-receptor blocker: implication of bradykinin-dependent and bradykinin-independent mechanisms. Circulation. 2000;102(Supl 3):346\u201351.","journal-title":"Circulation"},{"key":"6503_CR43","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1592\/phco.23.14.1401.31947","volume":"23","author":"JD Flynn","year":"2003","unstructured":"Flynn JD, Akers WS. Effects of the angiotensin II subtype 1 receptor antagonist losartan on functional recovery of isolated rat hearts undergoing global myocardial ischemia-reperfusion. Pharmacotherapy. 2003;23:1401\u201310.","journal-title":"Pharmacotherapy"},{"key":"6503_CR44","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.lfs.2012.03.006","volume":"90","author":"P Tsounapi","year":"2012","unstructured":"Tsounapi P, Saito M, Dimitriadis F, Kitatani K, Kinoshita Y, Shomori K, et al. The role of KATP channels on ischemia-reperfusion injury in the rat testis. Life Sci. 2012;90:649\u201356.","journal-title":"Life Sci"},{"key":"6503_CR45","doi-asserted-by":"crossref","first-page":"17561","DOI":"10.1074\/jbc.275.23.17561","volume":"23","author":"J Seharaseyon","year":"2000","unstructured":"Seharaseyon J, Sasaki N, Ohler A, Sato T, Fraser H, Johns DC, et al. Evidence against functional heteromultimerization of the KATP channel subunits Kir6.1 and Kir6.2. 275. J Biol Chem. 2000;23:17561\u20135.","journal-title":"J Biol Chem"},{"key":"6503_CR46","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1161\/CIRCRESAHA.108.178186","volume":"103","author":"TP Flagg","year":"2008","unstructured":"Flagg TP, Kurata HT, Masia R, Caputa G, Magnuson MA, Lefer DJ, et al. Differential structure of atrial and ventricular KATP: atrial KATP channels require SUR1. Circ Res. 2008;103:1458\u201365.","journal-title":"Circ Res"},{"key":"6503_CR47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1472-6793-5-1","volume":"5","author":"A Morrissey","year":"2005","unstructured":"Morrissey A, Rosner E, Lanning J, Parachuru L, Chowdhury PD, Han S, et al. Immunolocalization of KATP channel subunits in mouse and rat cardiac myocytes and the coronary vasculature. BMC Physiol. 2005;5:1.","journal-title":"BMC Physiol"},{"key":"6503_CR48","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1006\/jmcc.2000.1226","volume":"32","author":"J Seharaseyon","year":"2000","unstructured":"Seharaseyon J, Ohler A, Sasaki N, Fraser H, Sato T, Johns DC, et al. Molecular composition of mitochondrial ATP-sensitive potassium channels probed by viral Kir gene transfer. J Mol Cell Cardiol. 2000;32:1923\u201330.","journal-title":"J Mol Cell Cardiol"},{"key":"6503_CR49","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.mito.2004.12.001","volume":"5","author":"DV Cuong","year":"2005","unstructured":"Cuong DV, Kim N, Joo H, Youm JB, Chung J-Y, Lee Y, et al. Subunit composition of ATP-sensitive potassium channels in mitochondria of rat hearts. Mitochondrion. 2005;5:121\u201333.","journal-title":"Mitochondrion"},{"key":"6503_CR50","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.bbrc.2007.11.154","volume":"366","author":"DB Foster","year":"2008","unstructured":"Foster DB, Rucker JJ, Marb\u00e1n E. Is Kir6.1 a subunit of mitoKATP? Biochem Biophys Res Commun. 2008;366:649\u201356.","journal-title":"Biochem Biophys Res Commun"},{"key":"6503_CR51","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/j.1469-7793.1997.489bg.x","volume":"503","author":"M Kubo","year":"1997","unstructured":"Kubo M, Quayle JM, Standen NB. Angiotensin II inhibition of ATP-sensitive K+ currents in rat arterial smooth muscle cells through protein kinase C. J Physiol. 1997;503:480\u201396.","journal-title":"J Physiol"},{"key":"6503_CR52","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.cardiores.2007.05.020","volume":"76","author":"LJ Sampson","year":"2007","unstructured":"Sampson LJ, Davies LM, Barrett-Jolley R, Standen NB, Dart C. Angiotensin II-activated protein kinase C targets caveolae to inhibit aortic ATPsensitive potassium channels. Cardiovasc Res. 2007;76:61\u201370.","journal-title":"Cardiovasc Res"}],"container-title":["Cardiovascular Drugs and Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-013-6503-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10557-013-6503-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-013-6503-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,15]],"date-time":"2022-03-15T00:58:06Z","timestamp":1647305886000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10557-013-6503-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11,21]]},"references-count":52,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["6503"],"URL":"https:\/\/doi.org\/10.1007\/s10557-013-6503-8","relation":{},"ISSN":["0920-3206","1573-7241"],"issn-type":[{"value":"0920-3206","type":"print"},{"value":"1573-7241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,21]]}}}